Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease.
Hatano R, Itoh T, Otsuka H, Saeki H, Yamamoto A, Song D, Shirakawa Y, Iyama S, Sato T, Iwao N, Harada N, Aune TM, Dang NH, Kaneko Y, Yamada T, Morimoto C, Ohnuma K.
Hatano R, et al. Among authors: aune tm.
Am J Transplant. 2022 Dec;22(12):2804-2820. doi: 10.1111/ajt.17178. Epub 2022 Sep 9.
Am J Transplant. 2022.
PMID: 35997569
Free article.